Lanean...

The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice

BACKGROUND: The hallmark of Type 2 diabetes (T2D) is hyperglycemia, although there are multiple other metabolic abnormalities that occur with T2D, including insulin resistance and dyslipidemia. To advance T2D prevention and develop targeted therapies for its treatment, a greater understanding of the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nutr Metab (Lond)
Egile Nagusiak: Kumar, Amit, Shiloach, Joseph, Betenbaugh, Michael J, Gallagher, Emily J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362840/
https://ncbi.nlm.nih.gov/pubmed/25784953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-015-0003-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!